Walgreens, Teva accused of fueling opioid addiction in quest for new markets - PharmaLive
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
Exclusive: CVS to Cover Migraine Drugs From Teva, Lilly; Excludes Amgen
Teva enters billion-dollar settlement in US opioid case — MedWatch
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Teva expects lower profits in 2024 despite a strong Q4 performance | Ctech
Teva to pay $85m to Oklahoma over opioid case
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
NY Attorney General says Teva lied on opioids - Globes
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceutical Is in Recovery - WSJ
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
AstraZeneca slumps on report CEO is heading to Teva – New York Daily News
U.S. states sue Mylan, Teva, others for fixing drug prices - Mitchell Republic | News, weather, sports from Mitchell South Dakota
What's 'down' with Teva? - Israel News - The Jerusalem Post
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | SaltWire
Teva Pharm to lay off a quarter of workforce
Exclusive: Teva poised to raise its stake in Mylan - sources
Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Why Europe's Drug Shortages May Get Worse
Teva CEO exits amid crisis of confidence at drugmaker | Fox Business
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceutical Industries isn't out of the woods yet -February 01, 2024 at 04:41 am EST | MarketScreener
